4Filed Sep 16, 8:00 PM ET
Travere (TVTX) CFO Christopher Cline Exercises Options, Sells Shares
$TVTX · Travere Therapeutics, Inc.Research Summary
AI-generated summary of this SEC filing
Travere (TVTX) CFO Christopher Cline Exercises Options, Sells Shares
What Happened
- Christopher R. Cline, Chief Financial Officer of Travere Therapeutics (TVTX), exercised stock options and sold shares on September 15, 2026. He exercised 20,000 options at $17.44 (cost $348,800) and an additional 20,000 option-related shares were reported as a derivative conversion/disposition (reported at $0.00). He sold a total of 50,508 shares in multiple open-market transactions that day for aggregate proceeds of approximately $3,148,544.
Key Details
- Transaction date: September 15, 2026; Form 4 filed September 17, 2026 (timely filing).
- Sales breakdown (reported blocks):
- 27,473 shares @ $62.00 — $1,703,241 (F1/F2)
- 20,735 shares @ $62.61 — $1,298,175 (F3)
- 1,900 shares @ $63.69 — $121,004 (F4)
- 400 shares @ $65.31 — $26,124 (F4)
- Exercise: 20,000 shares @ $17.44 (paid $348,800); another 20,000 reported as exercised/converted/disposed at $0.00 in the filing (derivative line).
- Net flow that day (based on reported items): acquired 20,000 shares by paid exercise and sold 50,508 shares — a net disposition of ~30,508 shares.
- Shares owned after transaction: not specified in the details provided here (not included in the supplied data).
- Footnotes of note:
- F1: Some sales made under a written 10b5-1 trading plan adopted June 16, 2026; sales include shares underlying a stock option expiring May 17, 2027.
- F2–F4: Weighted-average sale prices and price ranges provided for the reported sale blocks; full per-price detail available upon request.
- F5: The stock option involved was fully vested and exercisable.
- No late filing flag in the supplied data; filing appears to have been made within the normal Form 4 window.
Context
- The filing shows option exercise(s) (derivative code M) and same-day open-market sales. This pattern is commonly a cashless exercise or planned disposition under a 10b5-1 plan, meaning the sales were prearranged and routine; such sales are informational but not necessarily a signal of management view. Purchases (bullish signals) tend to carry more weight than routine, preplanned sales.